ARV-102: First-in-Human Data Shows Blood-Brain Barrier Penetration
Arvinas presented positive Phase 1 clinical trial data for ARV-102, a PROTAC degrader targeting LRRK2, a protein implicated in...
eClinical Tech News
Anavex Life Sciences Announces Positive 4-Year Blarcamesine Results
Anavex Life Sciences announced positive data from its ATTENTION-AD trial, a long-term extension of a Phase 2b/3 study evaluating...
Cingulate Completes Pre-NDA Meeting with FDA for CTX-1301
Cingulate Inc. held a Pre-NDA meeting with the FDA to discuss its new drug application for CTx-1301, a treatment...
Pacira Initiates Phase 2 Osteoarthritis Knee Study
Pacira BioSciences has initiated a Phase 2 clinical trial, ASCEND, for PCRX-201, a locally administered gene therapy designed to...
FibroBiologics Announces Breakthrough Brain Tissue Repair Results
FibroBiologics, a clinical-stage biotech company, announced positive results from a preclinical study investigating the use of intravenous fibroblasts to...
Johns Hopkins Doses Nasal Foralumab in MS Trial
Tiziana Life SciencesLife Sciences has initiated dosing at Johns Hopkins University, the third site in its Phase 2 trial...
Acumen’s P-tau217 Trial Shows Progress in Phase 2 & Preclinical Research
Acumen Pharmaceuticals presented extended results from its plasma pTau217 assay used to screen participants in the Phase 2 ALTITUDE-AD...
Neflamapimod Shows Promise in Slowing Dementia with Lewy Bodies Progression
CervoMed announced positive 16-week results from the extension phase of its Phase 2b RewinD-LB study of neflamapimod for dementia...
Enormous Parkinson’s Breakthrough: Phase 2 Trial Shows Positive Results
AC Immune announced positive interim Phase 2 trial results for ACI-7104.056, an active immunotherapy targeting alpha-synuclein (a-syn) in early...
Connect Biopharma’s Positive Type C Meeting with FDA for Radmikibart
Connect Biopharma announced positive feedback from the FDA regarding its plan for two Phase 2 trials of rademikibart. The...